PARP inhibitors in pancreatic cancer: molecular mechanisms and clinical applications
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-4598
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
PARP inhibitors in pancreatic cancer: molecular mechanisms and clinical applications ; volume:19 ; number:1 ; day:2 ; month:3 ; year:2020 ; pages:1-15 ; date:12.2020
Molecular cancer ; 19, Heft 1 (2.3.2020), 1-15, 12.2020
- Urheber
-
Zhu, Heng
Wei, Miaoyan
Xu, Jin
Hua, Jie
Liang, Chen
Meng, Qingcai
Zhang, Yiyin
Liu, Jiang
Zhang, Bo
Yu, Xianjun
Shi, Si
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12943-020-01167-9
- URN
-
urn:nbn:de:101:1-2020052417231420766990
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 11:04 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zhu, Heng
- Wei, Miaoyan
- Xu, Jin
- Hua, Jie
- Liang, Chen
- Meng, Qingcai
- Zhang, Yiyin
- Liu, Jiang
- Zhang, Bo
- Yu, Xianjun
- Shi, Si
- SpringerLink (Online service)
Ähnliche Objekte (12)
The reciprocal regulation between host tissue and immune cells in pancreatic ductal adenocarcinoma: new insights and therapeutic implications
Ferroptosis, necroptosis, and pyroptosis in anticancer immunity
Comprehensive analysis of the prognosis and immune infiltration landscape of RNA methylation-related subtypes in pancreatic cancer
The promising role of noncoding RNAs in cancer-associated fibroblasts: an overview of current status and future perspectives
A PD-L2-based immune marker signature helps to predict survival in resected pancreatic ductal adenocarcinoma
The microbiota and microbiome in pancreatic cancer: more influential than expected
Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives
Turning up the heat on non-immunoreactive tumors: autophagy influences the immune microenvironment in pancreatic cancer
Role of tumor mutation burden-related signatures in the prognosis and immune microenvironment of pancreatic ductal adenocarcinoma
Circular RNA CircEYA3 induces energy production to promote pancreatic ductal adenocarcinoma progression through the miR-1294/c-Myc axis
Radical antegrade modular pancreatosplenectomy (RAMPS) versus standard retrograde pancreatosplenectomy (SRPS) for resectable body and tail pancreatic adenocarcinoma: protocol of a multicenter, prospective, randomized phase III control trial (CSPAC-3)
Topical application of Glauber’s salt accelerates the absorption of abdominal fluid after pancreatectomy
The reciprocal regulation between host tissue and immune cells in pancreatic ductal adenocarcinoma: new insights and therapeutic implications
Ferroptosis, necroptosis, and pyroptosis in anticancer immunity
Comprehensive analysis of the prognosis and immune infiltration landscape of RNA methylation-related subtypes in pancreatic cancer
The promising role of noncoding RNAs in cancer-associated fibroblasts: an overview of current status and future perspectives
A PD-L2-based immune marker signature helps to predict survival in resected pancreatic ductal adenocarcinoma
The microbiota and microbiome in pancreatic cancer: more influential than expected
Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives
Turning up the heat on non-immunoreactive tumors: autophagy influences the immune microenvironment in pancreatic cancer
Role of tumor mutation burden-related signatures in the prognosis and immune microenvironment of pancreatic ductal adenocarcinoma
Circular RNA CircEYA3 induces energy production to promote pancreatic ductal adenocarcinoma progression through the miR-1294/c-Myc axis
Radical antegrade modular pancreatosplenectomy (RAMPS) versus standard retrograde pancreatosplenectomy (SRPS) for resectable body and tail pancreatic adenocarcinoma: protocol of a multicenter, prospective, randomized phase III control trial (CSPAC-3)
Topical application of Glauber’s salt accelerates the absorption of abdominal fluid after pancreatectomy
The reciprocal regulation between host tissue and immune cells in pancreatic ductal adenocarcinoma: new insights and therapeutic implications
Ferroptosis, necroptosis, and pyroptosis in anticancer immunity
Comprehensive analysis of the prognosis and immune infiltration landscape of RNA methylation-related subtypes in pancreatic cancer
The promising role of noncoding RNAs in cancer-associated fibroblasts: an overview of current status and future perspectives
A PD-L2-based immune marker signature helps to predict survival in resected pancreatic ductal adenocarcinoma
The microbiota and microbiome in pancreatic cancer: more influential than expected
Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives
Turning up the heat on non-immunoreactive tumors: autophagy influences the immune microenvironment in pancreatic cancer
Role of tumor mutation burden-related signatures in the prognosis and immune microenvironment of pancreatic ductal adenocarcinoma
Circular RNA CircEYA3 induces energy production to promote pancreatic ductal adenocarcinoma progression through the miR-1294/c-Myc axis
Radical antegrade modular pancreatosplenectomy (RAMPS) versus standard retrograde pancreatosplenectomy (SRPS) for resectable body and tail pancreatic adenocarcinoma: protocol of a multicenter, prospective, randomized phase III control trial (CSPAC-3)